{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:31:04Z","timestamp":1775485864055,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH092797"],"award-info":[{"award-number":["MH092797"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS061025"],"award-info":[{"award-number":["NS061025"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS075527"],"award-info":[{"award-number":["NS075527"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS134586"],"award-info":[{"award-number":["NS134586"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS103988"],"award-info":[{"award-number":["NS103988"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006309","name":"American Parkinson Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118647","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:05:06Z","timestamp":1770534306000},"page":"118647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and characterization of F-18 sigma-1 receptor radiotracers for Alzheimer disease"],"prefix":"10.1016","volume":"307","author":[{"given":"Hao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip B.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Soda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-835X","authenticated-orcid":false,"given":"Zhude","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118647_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ejmech.2026.118647_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"Nguyen","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118647_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118647_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118647_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","article-title":"Selective vulnerability in neurodegenerative diseases","volume":"21","author":"Fu","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118647_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(93)91441-T","article-title":"Loss of sigma binding sites in the CA1 area of the anterior hippocampus in alzheimer's disease correlates with CA1 pyramidal cell loss","volume":"623","author":"Jansen","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2026.118647_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma1 receptors in early alzheimer's disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.118647_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk1051","article-title":"Widespread cell stress and mitochondrial dysfunction occur in patients with early alzheimer's disease","volume":"14","author":"Venkataraman","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118647_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-024-01462-3","article-title":"N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk","volume":"16","author":"Cheng","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejmech.2026.118647_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/alz.069100","article-title":"An M1\/sigma\u20101 receptor agonist prevents cognitive deficits, reduces amyloid plaques and neuroinflammation in a transgenic rat model of Alzheimer's amyloid pathology","volume":"18","author":"Orciani","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2026.118647_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000440864","article-title":"AF710B, a novel M1\/sigma1 agonist with therapeutic efficacy in animal models of alzheimer's disease","volume":"16","author":"Fisher","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejmech.2026.118647_bib12","series-title":"PET and SPECT of Neurobiological Systems","first-page":"943","article-title":"PET imaging of Sigma1 receptors","author":"Toyohara","year":"2021"},{"key":"10.1016\/j.ejmech.2026.118647_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/(SICI)1099-1344(199609)38:9<785::AID-JLCR901>3.0.CO;2-B","article-title":"Synthesis of [18F]-1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)-piperidine: a potential sigma-1 receptor radioligand for PET","volume":"38","author":"Lee Collier","year":"1996","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2026.118647_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13550-015-0122-2","article-title":"Further validation to support clinical translation of [18F]FTC-146 for imaging sigma-1 receptors","volume":"5","author":"Shen","year":"2015","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ejmech.2026.118647_bib15","article-title":"Assessing the chiral selectivity of a sigma-1 receptor radiotracer: a PET imaging study of (R)- and (S)-18F-FBFP in non-human Primates","volume":"63","author":"Zheng","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.118647_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0969-8051(99)00033-5","article-title":"In vivo binding of [11c]nemonapride to sigma receptors in the cortex and cerebellum","volume":"26","author":"Ishiwata","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.118647_bib17","first-page":"32","article-title":"Synthesis, radiolabelling, and evaluation of [(11)C]PB212 as a radioligand for imaging sigma-1 receptors using PET","volume":"8","author":"Spinelli","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejmech.2026.118647_bib18","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.7150\/thno.47585","article-title":"Evaluation of (18)F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in vivo in rodents and in human tissue","volume":"10","author":"Lepelletier","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.118647_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.apsb.2019.07.002","article-title":"Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)","volume":"9","author":"Lan","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118647_bib20","series-title":"Molecular Imaging and Contrast Agent Database (MICAD)","article-title":"1-(4-[(18)F]Fluoromethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine","author":"Cheng","year":"2004"},{"key":"10.1016\/j.ejmech.2026.118647_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/syn.20207","article-title":"a potential fluorine-18 labeled PET radiotracer for imaging sigma-1 receptors in the CNS","volume":"58","author":"Mach","year":"2005","journal-title":"Synapse (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2026.118647_bib22","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/acs.jmedchem.3c02178","article-title":"Molecular imaging of alzheimer's disease-related Sigma-1 receptor in the brain via a novel Ru-Mediated aromatic (18)F-deoxyfluorination probe","volume":"67","author":"Bai","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.943512","article-title":"Four decades of mapping and quantifying neuroreceptors at work in vivo by positron emission tomography","volume":"16","author":"Gjedde","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118647_bib24","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/jm5001453","article-title":"Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as sigma2 receptor ligands","volume":"57","author":"Bai","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13065-016-0200-1","article-title":"4-aroylpiperidines and 4-(alpha-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies","volume":"10","author":"Ikome","year":"2016","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2026.118647_bib26","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1021\/jm200203f","article-title":"Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for sigma1 receptors","volume":"54","author":"Wang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1039\/C4MD00240G","article-title":"Radiosynthesis and in vivo evaluation of a novel sigma(1) selective PET ligand","volume":"5","author":"Jin","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2026.118647_bib28","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bmc.2017.01.017","article-title":"Chiral resolution of serial potent and selective sigma(1) ligands and biological evaluation of (-)-[(18)F]TZ3108 in rodent and the nonhuman primate brain","volume":"25","author":"Yue","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031997","article-title":"Sigma-1 receptor signaling: in search of new therapeutic alternatives for cardiovascular and renal diseases","volume":"24","author":"Munguia-Galaviz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118647_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.685201","article-title":"Sigma-1 receptor: a potential therapeutic target for traumatic brain injury","volume":"15","author":"Shi","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118647_bib31","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1021\/acs.orglett.6b00876","article-title":"Direct conversion of haloarenes to phenols under mild, transition-metal-free conditions","volume":"18","author":"Fier","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118647_bib29","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.apradiso.2010.06.004","article-title":"Radiosynthesis and biological evaluation of a promising sigma(2)-receptor ligand radiolabeled with fluorine-18 or iodine-125 as a PET\/SPECT probe for imaging breast cancer","volume":"68","author":"Tu","year":"2010","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2026.118647_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nucmedbio.2005.10.007","article-title":"In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors","volume":"33","author":"Waterhouse","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.118647_bib32","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1002\/ejoc.201501042","article-title":"Ether cleavage re-investigated: elucidating the mechanism of BBr(3)-Facilitated demethylation of aryl methyl ethers","volume":"2015","author":"Kosak","year":"2015","journal-title":"European J Org Chem"},{"key":"10.1016\/j.ejmech.2026.118647_bib33","doi-asserted-by":"crossref","first-page":"118218","DOI":"10.1016\/j.bmc.2025.118218","article-title":"Radiosynthesis and in vivo evaluation of six Carbon-11 radiotracers for imaging the Sigma-1 receptor in the brain. Bioorg","volume":"126","author":"Soda","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfluchem.2024.110367","article-title":"Two F-18 radiochemistry methods to synthesize a promising transient receptor potential canonical 5 (TRPC5) radioligand","volume":"280","author":"Yu","year":"2024","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.ejmech.2026.118647_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(00)00430-1","article-title":"Correlation between neuroleptic binding to sigma(1) and sigma(2) receptors and acute dystonic reactions","volume":"401","author":"Matsumoto","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118647_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1471-4159.2007.04533.x","article-title":"Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in Guinea pig brain and SH-SY5Y human neuroblastoma cells","volume":"102","author":"Cobos","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.118647_bib37","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1073\/pnas.1300677110","article-title":"Modulation of the endoplasmic reticulum\u2013mitochondria interface in Alzheimer's disease and related models","volume":"110","author":"Hedskog","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118647_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091164","article-title":"Evaluation of the enantiomer specific biokinetics and radiation doses of [(18)F]Fluspidine-A new tracer in clinical translation for imaging of \u03c31 receptors","volume":"21","author":"Kranz","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118647_bib39","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2967\/jnumed.114.137562","article-title":"Distinctive in vivo kinetics of the new \u03c31 receptor ligands (R)-(+)- and (S)-(\u2013)-18F-Fluspidine in porcine brain","volume":"55","author":"Brust","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.118647_bib40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jnc.15693","article-title":"Specific detection and deletion of the sigma-1 receptor widely expressed in neurons and glial cells in vivo","volume":"164","author":"Liu","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.118647_bib41","article-title":"Sigma-1 receptor in retina: neuroprotective effects and potential mechanisms","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118647_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/acsmedchemlett.1c00002","article-title":"Sigma-1 and Sigma-2 receptor modulators as potential therapeutics for alzheimer's disease","volume":"12","author":"Kargbo","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118647_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of alzheimer's disease with plaques and tangles: intracellular abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.118647_bib46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2026.118647_bib47","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/chem.202005158","article-title":"Electro-oxidative selective esterification of methylarenes and benzaldehydes","volume":"27","author":"Yu","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2026.118647_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(94)90102-3","article-title":"[3H](+)-Pentazocine binding to rat brain \u03c31 receptors","volume":"266","author":"Cagnotto","year":"1994","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118647_bib49","first-page":"15","article-title":"Characterization of Sigma-2 receptor-specific binding sites using [(3)H]DTG and [(125)I]RHM-4","author":"Weng","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118647_bib50","volume":"2021","author":"Jiang","year":"2021"},{"key":"10.1016\/j.ejmech.2026.118647_bib51","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1021\/acschemneuro.1c00492","article-title":"InVitro and in vivo investigation of S1PR1 expression in the central nervous system using [(3)H]CS1P1 and [(11)C]CS1P1","volume":"12","author":"Jiang","year":"2021","journal-title":"ACS Chem. Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:40:26Z","timestamp":1775482826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S0223523426000929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118647","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and characterization of F-18 sigma-1 receptor radiotracers for Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118647"}}